The Danish medical cannabis company will IPO today on the Swedish Stock Exchange Spotlight (former "Aktietorget"). The stock is 20 times oversubscribed and the valuation of the company is DKK 59.7m. Prior to the general offering, private investors already subscribed shares for DKK 11m. Stenocare reported zero sales and negative EBIT and EBITDA in the financial statement in the prospectus.
